.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeMarket Insights Snapshot
In October 2026, Redecan’s mix is anchored by Pre-Roll at 52.05% share (ranked #9 in Pre-Roll in Ontario), but that anchor is eroding with a -34.07% YoY sales decline and a -5.14% MoM dip, while Flower at 21.90% share contracted more sharply at -63.91% YoY and -9.95% MoM. Countering those contractions, Vapor Pens rose 78.45% YoY and 1.80% MoM to 10.01% share, and Oil gained 15.40% MoM despite a -6.54% YoY slide to 10.13% share; Capsules held 5.91% share with -18.30% YoY and 8.85% MoM. The pattern implies Redecan is rotating out of higher-volume inhalables led by Flower into steadier or expanding formats like Vapor Pens and Oil, using Pre-Roll scale to cushion but not prevent mix dilution.
The shift toward Vapor Pens at a 78.45% YoY increase and Oil with a 15.40% MoM lift, alongside a -34.07% YoY drop in Pre-Roll and -63.91% YoY in Flower, implies a repositioning from value-led combustion to differentiated, higher-avg-price formats (Vapor Pens at $40.82 vs brand average price down 1.00% YoY). With Pre-Roll still over half of sales at 52.05% yet slipping -5.14% MoM, maintaining a #9 rank in Ontario likely requires defending core SKUs while reallocating assortment toward Vapor Pens and Oil where share (10.01% and 10.13%) can compound; the thesis is that margin-mix can improve even as total sales fell 38.76% YoY if growth categories scale faster than Pre-Roll and Flower declines.
Competitive Landscape
Redecan is ranked #9 in ON Pre-Roll in October 2026, down four places from #5 in October 2025, and two places from #7 in July 2026, while its historical peak was #4 in November 2025; in contrast, Back Forty / Back 40 Cannabis moved from #2 to #1 with a 75.6% year-over-year sales increase and General Admission slid from #1 to #2 alongside a 28.3% sales decline. The mid-pack ascent of Thumbs Up Brand from #10 to #3 and Spinach from #17 to #4, coupled with Claybourne Co. easing from #4 to #5 with a 12.4% drop, indicates competitive displacement rather than category contraction; the trajectory from #4 in November 2025 to #9 in October 2026 implies Redecan is ceding rank share to faster-rising value and flavor-led rivals and must decide whether to chase volume or concentrate on defensible niches.
Notable Products
Redecan’s sales in October 2026 are tightly concentrated, with the top 10 items delivering 61.7% of brand revenue and the lead SKU, Redees- Hemp'd Animal Runtz Pre-Roll 10-Pack (4g), alone at 13.0%. New launches contribute just 0.4%, so most of its sales ride on a relatively small core set of products.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
